arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Unicycive Therapeutics, Inc.

UNCY

$4.82 ▼ -0.13 (-2.63%) at close

27 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Unicycive Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $129.7M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -15.0% ↗

FCF / Share $-0.28 ↘

Trailing P/E —

Price / Book 2.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-12.82M

— 0.0% —

FCF / Share Free cash flow per share

$-0.28

↓ -8.1% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	88.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	—	68.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-560.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	—	-1550.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	61.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	37.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	54.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	64.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-20.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-304.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-105.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	-118.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	N/M	31.9% Excellent Excellent Year-over-year change in net income	N/M	N/M	N/M	-176.0% Weak ↓ Weak Declining Year-over-year change in net income	-43.8% Weak → Weak Stable Year-over-year change in net income	-43.8% Weak ↑ Weak Improving Year-over-year change in net income	-43.8% Weak ↑ Weak Improving Year-over-year change in net income	-46.4% Weak ↑ Weak Improving Year-over-year change in net income	-312.1% Weak ↓ Weak Declining Year-over-year change in net income	-312.1% Weak ↓ Weak Declining Year-over-year change in net income	-312.1% Weak ↓ Weak Declining Year-over-year change in net income	-93.6% Weak ↑ Weak Improving Year-over-year change in net income	32.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-221.5% Weak ↑ Weak Improving Year-over-year change in net income	-266.9% Weak ↑ Weak Improving Year-over-year change in net income	-212.7% Weak ↑ Weak Improving Year-over-year change in net income	-640.9% Weak Weak Year-over-year change in net income	-225.4% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	-242.3% Weak Weak Year-over-year change in free cash flow	—	—	—	58.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	28.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-30.5% Weak Weak Year-over-year change in free cash flow	—	—	—	-151.3% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-371.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3199%)	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.59x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-10.46x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	-15.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.31x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	—	0.30x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.31x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.27x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.14x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.70x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-15.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-33.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-56.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-98.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	39.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	29.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	130.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-138.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	17.6% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	—	902.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-94.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	14.6% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	17.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	21.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	26.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	20.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-14.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-13.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-17.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-44.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-30.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-189.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-54.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-85.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-351.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-24.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-260%)	-34.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-327%)	-48.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-424%)	1.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-90%)	3.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-77%)	5.1% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-66%)	-289.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-2031%)	-75.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-602%)	141.2% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+841%)	85.7% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+471%)	204.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1265%)	—	75.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+402%)	96.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+544%)	—	-76.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-610%)	-35.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-338%)	-26.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-278%)	-16.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-211%)	-27.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-283%)	26.2% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+75%)	28.3% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+89%)	32.9% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+120%)	37.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+152%)	25.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+73%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	—	—	—	—	—	-1331.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-237.46x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-416.73x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-238.74x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-460.20x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-329.89x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-135.06x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-1775.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1851.33x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-85.73x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2.43x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.90x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.40x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.24x Weak Weak Operating income divided by interest expense Optimal: > 5x	-168.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-44.19M	$-37.37M	$-29.20M	$-42.70M	$-22.33M	$-19.77M	$-26.14M	—	—	—	—	$-14.35M	$-18.82M	$-24.33M	—	$-7.01M	$-10.57M	$-13.62M	$-16.58M	$-18.01M	$-1.00K	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.04	—	$0.06	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.06	$-0.54	$-0.82	$-0.33	$-0.52	—	$-2.64	$-0.05	$0.80	$-0.61	$-0.16	$-0.13	$-0.29	$-0.97	$-0.35	$-0.37	$-0.24	$-0.24	$-0.17	—	—	$-0.11	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.28	$-0.26	—	$-0.33	—	$-0.08	—	—	$-1.67	$-0.19	—	—	—	$-0.26	—	—	—	$-0.20	—	—	—	$-0.08	—	—	—	—	—
Book Value per Share (USD)	$1.91	$1.49	$1.37	$1.80	$1.16	$0.09	$0.65	$0.28	$-3.92	$-0.65	$-0.11	$0.10	$-1.27	$-0.99	$-0.03	$0.31	$0.66	$0.88	$1.10	$1.27	$-0.48	$-0.40	$-0.31	—	—	—	—
Tangible Book Value per Share (USD)	$1.91	$1.49	$1.37	$1.80	$1.16	$0.09	$0.65	$0.28	$-3.92	$-0.65	$-0.11	$0.10	$-1.27	$-0.99	$-0.03	$0.31	$0.66	$0.88	$1.10	$1.27	$-0.48	$-0.40	$-0.31	—	—	—	—
Basic Weighted Avg Shares (shares)	26.92M	23.91M	—	18.07M	12.30M	116.82M	—	88.94M	3.79M	34.91M	—	32.63M	15.23M	15.23M	—	15.06M	15.03M	15.00M	—	—	—	8.58M	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$52.62M	$37.06M	$30.02M	$37.16M	$15.96M	$10.67M	$6.83M	$27.28M	—	$21.39M	$-4.13M	$3.11M	$6.51M	$10.21M	$-640.00K	$4.44M	$9.73M	$13.06M	$16.31M	$19.00M	$-4.20M	—	$-2.67M	—	—	—	—
Total Equity (USD)	$53.27M	$37.70M	$30.20M	$37.48M	$16.43M	$11.27M	$7.43M	$27.85M	$-14.85M	$-24.46M	$-3.81M	$3.39M	$-19.37M	$-15.08M	$-466.00K	$4.63M	$9.91M	$13.24M	$16.48M	$19.00M	$-4.20M	$-3.40M	$-2.67M	$-1.86M	$-1.30M	$-1.15M	$-884.00K

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	$0.00	—	—	$675.00K	$0.00	$951.00K	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$6.00K	$8.00K	$10.00K	$10.00K	—	$8.00K	$7.00K	—	$0.00	$9.00K	$3.00K	—	—	$2.00K	$2.00K	—	—	$2.00K	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-12.82M	$-12.82M	$-14.67M	$570.00K	$570.00K	$570.00K	$-21.52M	$-20.96M	$-20.96M	$-20.96M	$-7.80M	$-14.57M	$-14.57M	$-14.57M	$-5.33M	$-3.54M	$-3.54M	$-3.54M	$-2.75M	$-5.20M	$-1.10M	$-964.00K	$-880.00K	$-702.00K	$-338.00K	—	—
Operating Cash Flow (USD)	$-7.60M	$-6.24M	$-8.03M	$-5.96M	—	$-8.90M	$-6.55M	—	$-6.32M	$-6.46M	$-4.44M	—	—	$-3.92M	$-6.08M	—	—	$-2.96M	$-1.40M	—	—	$-673.00K	$-538.00K	$-706.00K	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 27 quarters

Unicycive Therapeutics, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare UNCY with peers